"I am overwhelmed and humbled by the tremendous support and well-wishes I have received from my friends and fellow Lilly colleagues around the world," Dr. Lechleiter said. "I return to Lilly with renewed energy and enthusiasm, along with a new perspective on health and wellness and the critical importance of new medicines in advancing patient care.
"I want to thank and acknowledge Derica Rice for the important role he played during my absence, as well as Ellen Marram for her leadership of the Lilly board," he added.
Derica W. Rice will continue in his role as executive vice president, global services and chief financial officer. Mr. Rice had assumed the additional role of acting chief executive officer during Dr. Lechleiter's medical leave. Ellen R. Marram will continue in her role as the board's lead independent director after serving as acting chairperson of the board during that time.